在质瘤中MRI成像的进步:神经外科医生需要知道的
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. anna.falk.delgado@ki.se.
Acta neurochirurgica
|June 21, 2025
概括
先进的MRI技术对于诊断和管理高度质瘤至关重要. 这些磁共振成像 (MRI) 方法改善了手术规划,治疗监测和区分瘤进展与其他疾病.
科学领域:
- 神经瘤学神经瘤学
- 放射学 放射学是一门学科.
- 神经外科 神经外科
背景情况:
- 高度质瘤,特别是质母细胞瘤,在神经瘤学中构成重大挑战,原因是透性生长,治疗耐药性和低生存率.
- 神经症状往往需要紧急的神经成像来诊断和区分其他疾病.
研究的目的:
- 审查先进的磁共振成像 (MRI) 技术在高等级质瘤的综合管理中的作用.
- 突出各种MRI模式如何在整个患者护理途径中为临床决策提供信息.
主要方法:
- 审查当前和新兴的先进的MRI技术,包括输液加权成像 (PWI),扩散加权成像 (DWI),功能性MRI (fMRI),扩散张力成像 (DTI),磁共振光谱,胺质子转移成像和2HG量化.
- 讨论MRI在初始诊断,术前规划,术后评估和治疗监测中的应用.
主要成果:
- 先进的MRI技术提高了诊断特异性,通过绘制关键大脑结构来帮助手术规划,并改善了瘤范围的评估.
- 手术后的MRI对于评估治疗反应,检测并发症和指导放射治疗至关重要.
- 在监测期间,MRI有助于区分瘤进展与伪进展或辐射死亡,从而影响后续的治疗策略.
结论:
- 先进的MRI技术是高度质瘤精密神经外科瘤学中不可或缺的工具.
- 持续的MRI技术的进步,包括机器学习的整合,将进一步提高临床决策和患者的结果.
相关概念视频
Magnetic Resonance Imaging
7.3K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.3K
Brain Imaging
321
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
321


